Christopher A. Van Tuyl's most recent trade in Immunovant Inc was a trade of 1,143 Common Stock done at an average price of $39.5 . Disclosure was reported to the exchange on July 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 39.53 per share. | 08 Jul 2026 | 1,143 | 179,454 (0%) | 0% | 39.5 | 45,183 | Common Stock |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 39.98 per share. | 08 Jul 2026 | 63 | 179,391 (0%) | 0% | 40.0 | 2,519 | Common Stock |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2026 | 17,824 | 53,707 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.20 per share. | 26 Jun 2026 | 17,824 | 198,421 (0%) | 0% | 15.2 | 270,925 | Common Stock |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 38.19 per share. | 26 Jun 2026 | 14,982 | 183,439 (0%) | 0% | 38.2 | 572,163 | Common Stock |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 38.96 per share. | 26 Jun 2026 | 2,842 | 180,597 (0%) | 0% | 39.0 | 110,724 | Common Stock |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 35.39 per share. | 18 Jun 2026 | 2,634 | 180,597 (0%) | 0% | 35.4 | 93,217 | Common Stock |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 08 Apr 2026 | 5,165 | 183,231 (0%) | 0% | 24.8 | 128,247 | Common Stock |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 59,820 | 59,820 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 41,343 | 188,396 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 24.97 per share. | 18 Mar 2026 | 2,877 | 147,053 (0%) | 0% | 25.0 | 71,839 | Common Stock |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 26.78 per share. | 18 Dec 2025 | 8,529 | 152,214 (0%) | 0% | 26.8 | 228,407 | Common Stock |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 27.38 per share. | 18 Dec 2025 | 2,284 | 149,930 (0%) | 0% | 27.4 | 62,536 | Common Stock |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 71,531 | 71,531 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Christopher A. Van Tuyl | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 50,787 | 160,743 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | A. Christopher Van Tuyl | Chief Legal Officer | 16 Dec 2024 | 137,446 | 137,446 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | A. Van Tuyl Christopher | Chief Legal Officer | 16 Dec 2024 | 109,956 | 109,956 (0%) | 0% | 0 | Common Stock |